Table of Content

1 Study Coverage
1.1 Pandemic Influenza Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Market by Application
1.3.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Pandemic Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Pandemic Influenza Vaccine Revenue by Region
2.2.1 Global Pandemic Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Pandemic Influenza Vaccine Revenue by Region (2018-2024)
2.2.3 Global Pandemic Influenza Vaccine Revenue by Region (2024-2029)
2.2.4 Global Pandemic Influenza Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Pandemic Influenza Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Pandemic Influenza Vaccine Sales by Region
2.4.1 Global Pandemic Influenza Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Pandemic Influenza Vaccine Sales by Region (2018-2024)
2.4.3 Global Pandemic Influenza Vaccine Sales by Region (2024-2029)
2.4.4 Global Pandemic Influenza Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Pandemic Influenza Vaccine Sales by Manufacturers
3.1.1 Global Pandemic Influenza Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pandemic Influenza Vaccine in 2022
3.2 Global Pandemic Influenza Vaccine Revenue by Manufacturers
3.2.1 Global Pandemic Influenza Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Pandemic Influenza Vaccine Revenue in 2022
3.3 Global Key Players of Pandemic Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Pandemic Influenza Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Pandemic Influenza Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Pandemic Influenza Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Pandemic Influenza Vaccine Sales by Type
4.1.1 Global Pandemic Influenza Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Pandemic Influenza Vaccine Revenue by Type
4.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Pandemic Influenza Vaccine Price by Type
4.3.1 Global Pandemic Influenza Vaccine Price by Type (2018-2024)
4.3.2 Global Pandemic Influenza Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Pandemic Influenza Vaccine Sales by Application
5.1.1 Global Pandemic Influenza Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Pandemic Influenza Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Pandemic Influenza Vaccine Revenue by Application
5.2.1 Global Pandemic Influenza Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Pandemic Influenza Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Pandemic Influenza Vaccine Price by Application
5.3.1 Global Pandemic Influenza Vaccine Price by Application (2018-2024)
5.3.2 Global Pandemic Influenza Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Pandemic Influenza Vaccine Market Size by Type
6.1.1 US & Canada Pandemic Influenza Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Pandemic Influenza Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Pandemic Influenza Vaccine Market Size by Application
6.2.1 US & Canada Pandemic Influenza Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Pandemic Influenza Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Pandemic Influenza Vaccine Market Size by Country
6.3.1 US & Canada Pandemic Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Pandemic Influenza Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Pandemic Influenza Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Pandemic Influenza Vaccine Market Size by Type
7.1.1 Europe Pandemic Influenza Vaccine Sales by Type (2018-2029)
7.1.2 Europe Pandemic Influenza Vaccine Revenue by Type (2018-2029)
7.2 Europe Pandemic Influenza Vaccine Market Size by Application
7.2.1 Europe Pandemic Influenza Vaccine Sales by Application (2018-2029)
7.2.2 Europe Pandemic Influenza Vaccine Revenue by Application (2018-2029)
7.3 Europe Pandemic Influenza Vaccine Market Size by Country
7.3.1 Europe Pandemic Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Pandemic Influenza Vaccine Sales by Country (2018-2029)
7.3.3 Europe Pandemic Influenza Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Pandemic Influenza Vaccine Market Size
8.1.1 China Pandemic Influenza Vaccine Sales (2018-2029)
8.1.2 China Pandemic Influenza Vaccine Revenue (2018-2029)
8.2 China Pandemic Influenza Vaccine Market Size by Application
8.2.1 China Pandemic Influenza Vaccine Sales by Application (2018-2029)
8.2.2 China Pandemic Influenza Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Pandemic Influenza Vaccine Market Size by Type
9.1.1 Asia Pandemic Influenza Vaccine Sales by Type (2018-2029)
9.1.2 Asia Pandemic Influenza Vaccine Revenue by Type (2018-2029)
9.2 Asia Pandemic Influenza Vaccine Market Size by Application
9.2.1 Asia Pandemic Influenza Vaccine Sales by Application (2018-2029)
9.2.2 Asia Pandemic Influenza Vaccine Revenue by Application (2018-2029)
9.3 Asia Pandemic Influenza Vaccine Sales by Region
9.3.1 Asia Pandemic Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Pandemic Influenza Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Pandemic Influenza Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Pandemic Influenza Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Pandemic Influenza Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Sanofi Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GSK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Viatris
11.4.1 Viatris Company Information
11.4.2 Viatris Overview
11.4.3 Viatris Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Viatris Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Viatris Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 AstraZeneca Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 AstraZeneca Recent Developments
11.6 Hualan Bio
11.6.1 Hualan Bio Company Information
11.6.2 Hualan Bio Overview
11.6.3 Hualan Bio Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Hualan Bio Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Hualan Bio Recent Developments
11.7 Changchun Institute of Biological
11.7.1 Changchun Institute of Biological Company Information
11.7.2 Changchun Institute of Biological Overview
11.7.3 Changchun Institute of Biological Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Changchun Institute of Biological Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Changchun Institute of Biological Recent Developments
11.8 Sinovac
11.8.1 Sinovac Company Information
11.8.2 Sinovac Overview
11.8.3 Sinovac Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Sinovac Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sinovac Recent Developments
11.9 BCHT
11.9.1 BCHT Company Information
11.9.2 BCHT Overview
11.9.3 BCHT Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 BCHT Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 BCHT Recent Developments
11.10 Jiangsu GDK
11.10.1 Jiangsu GDK Company Information
11.10.2 Jiangsu GDK Overview
11.10.3 Jiangsu GDK Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Jiangsu GDK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jiangsu GDK Recent Developments
11.11 KM Biologics
11.11.1 KM Biologics Company Information
11.11.2 KM Biologics Overview
11.11.3 KM Biologics Pandemic Influenza Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 KM Biologics Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 KM Biologics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Pandemic Influenza Vaccine Industry Chain Analysis
12.2 Pandemic Influenza Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pandemic Influenza Vaccine Production Mode & Process
12.4 Pandemic Influenza Vaccine Sales and Marketing
12.4.1 Pandemic Influenza Vaccine Sales Channels
12.4.2 Pandemic Influenza Vaccine Distributors
12.5 Pandemic Influenza Vaccine Customers
13 Market Dynamics
13.1 Pandemic Influenza Vaccine Industry Trends
13.2 Pandemic Influenza Vaccine Market Drivers
13.3 Pandemic Influenza Vaccine Market Challenges
13.4 Pandemic Influenza Vaccine Market Restraints
14 Key Findings in The Global Pandemic Influenza Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Trivalent Influenza Vaccine
Table 3. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 4. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Pandemic Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Pandemic Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Pandemic Influenza Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Pandemic Influenza Vaccine Sales by Region (2018-2024) & (M Units)
Table 12. Global Pandemic Influenza Vaccine Sales by Region (2024-2029) & (M Units)
Table 13. Global Pandemic Influenza Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Pandemic Influenza Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Pandemic Influenza Vaccine Sales by Manufacturers (2018-2024) & (M Units)
Table 16. Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Pandemic Influenza Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Pandemic Influenza Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Pandemic Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Pandemic Influenza Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Pandemic Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Pandemic Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pandemic Influenza Vaccine as of 2022)
Table 23. Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Pandemic Influenza Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Pandemic Influenza Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Pandemic Influenza Vaccine Sales by Type (2018-2024) & (M Units)
Table 28. Global Pandemic Influenza Vaccine Sales by Type (2024-2029) & (M Units)
Table 29. Global Pandemic Influenza Vaccine Sales Share by Type (2018-2024)
Table 30. Global Pandemic Influenza Vaccine Sales Share by Type (2024-2029)
Table 31. Global Pandemic Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Pandemic Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Pandemic Influenza Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Pandemic Influenza Vaccine Revenue Share by Type (2024-2029)
Table 35. Pandemic Influenza Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Pandemic Influenza Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Pandemic Influenza Vaccine Sales by Application (2018-2024) & (M Units)
Table 38. Global Pandemic Influenza Vaccine Sales by Application (2024-2029) & (M Units)
Table 39. Global Pandemic Influenza Vaccine Sales Share by Application (2018-2024)
Table 40. Global Pandemic Influenza Vaccine Sales Share by Application (2024-2029)
Table 41. Global Pandemic Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Pandemic Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Pandemic Influenza Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Pandemic Influenza Vaccine Revenue Share by Application (2024-2029)
Table 45. Pandemic Influenza Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Pandemic Influenza Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Pandemic Influenza Vaccine Sales by Type (2018-2024) & (M Units)
Table 48. US & Canada Pandemic Influenza Vaccine Sales by Type (2024-2029) & (M Units)
Table 49. US & Canada Pandemic Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Pandemic Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Pandemic Influenza Vaccine Sales by Application (2018-2024) & (M Units)
Table 52. US & Canada Pandemic Influenza Vaccine Sales by Application (2024-2029) & (M Units)
Table 53. US & Canada Pandemic Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Pandemic Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Pandemic Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Pandemic Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Pandemic Influenza Vaccine Sales by Country (2018-2024) & (M Units)
Table 59. US & Canada Pandemic Influenza Vaccine Sales by Country (2024-2029) & (M Units)
Table 60. Europe Pandemic Influenza Vaccine Sales by Type (2018-2024) & (M Units)
Table 61. Europe Pandemic Influenza Vaccine Sales by Type (2024-2029) & (M Units)
Table 62. Europe Pandemic Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Pandemic Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Pandemic Influenza Vaccine Sales by Application (2018-2024) & (M Units)
Table 65. Europe Pandemic Influenza Vaccine Sales by Application (2024-2029) & (M Units)
Table 66. Europe Pandemic Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Pandemic Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Pandemic Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Pandemic Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Pandemic Influenza Vaccine Sales by Country (2018-2024) & (M Units)
Table 72. Europe Pandemic Influenza Vaccine Sales by Country (2024-2029) & (M Units)
Table 73. China Pandemic Influenza Vaccine Sales by Type (2018-2024) & (M Units)
Table 74. China Pandemic Influenza Vaccine Sales by Type (2024-2029) & (M Units)
Table 75. China Pandemic Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Pandemic Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Pandemic Influenza Vaccine Sales by Application (2018-2024) & (M Units)
Table 78. China Pandemic Influenza Vaccine Sales by Application (2024-2029) & (M Units)
Table 79. China Pandemic Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Pandemic Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Pandemic Influenza Vaccine Sales by Type (2018-2024) & (M Units)
Table 82. Asia Pandemic Influenza Vaccine Sales by Type (2024-2029) & (M Units)
Table 83. Asia Pandemic Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Pandemic Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Pandemic Influenza Vaccine Sales by Application (2018-2024) & (M Units)
Table 86. Asia Pandemic Influenza Vaccine Sales by Application (2024-2029) & (M Units)
Table 87. Asia Pandemic Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Pandemic Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Pandemic Influenza Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Pandemic Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Pandemic Influenza Vaccine Sales by Region (2018-2024) & (M Units)
Table 93. Asia Pandemic Influenza Vaccine Sales by Region (2024-2029) & (M Units)
Table 94. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Type (2018-2024) & (M Units)
Table 95. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Type (2024-2029) & (M Units)
Table 96. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Application (2018-2024) & (M Units)
Table 99. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Application (2024-2029) & (M Units)
Table 100. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Country (2018-2024) & (M Units)
Table 106. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales by Country (2024-2029) & (M Units)
Table 107. Sanofi Company Information
Table 108. Sanofi Description and Major Businesses
Table 109. Sanofi Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Sanofi Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Sanofi Recent Developments
Table 112. CSL Company Information
Table 113. CSL Description and Major Businesses
Table 114. CSL Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. CSL Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Recent Developments
Table 117. GSK Company Information
Table 118. GSK Description and Major Businesses
Table 119. GSK Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. GSK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. GSK Recent Developments
Table 122. Viatris Company Information
Table 123. Viatris Description and Major Businesses
Table 124. Viatris Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Viatris Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Viatris Recent Developments
Table 127. AstraZeneca Company Information
Table 128. AstraZeneca Description and Major Businesses
Table 129. AstraZeneca Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. AstraZeneca Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. AstraZeneca Recent Developments
Table 132. Hualan Bio Company Information
Table 133. Hualan Bio Description and Major Businesses
Table 134. Hualan Bio Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Hualan Bio Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Hualan Bio Recent Developments
Table 137. Changchun Institute of Biological Company Information
Table 138. Changchun Institute of Biological Description and Major Businesses
Table 139. Changchun Institute of Biological Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Changchun Institute of Biological Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Changchun Institute of Biological Recent Developments
Table 142. Sinovac Company Information
Table 143. Sinovac Description and Major Businesses
Table 144. Sinovac Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Sinovac Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sinovac Recent Developments
Table 147. BCHT Company Information
Table 148. BCHT Description and Major Businesses
Table 149. BCHT Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. BCHT Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. BCHT Recent Developments
Table 152. Jiangsu GDK Company Information
Table 153. Jiangsu GDK Description and Major Businesses
Table 154. Jiangsu GDK Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Jiangsu GDK Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Jiangsu GDK Recent Developments
Table 157. KM Biologics Company Information
Table 158. KM Biologics Description and Major Businesses
Table 159. KM Biologics Pandemic Influenza Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. KM Biologics Pandemic Influenza Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. KM Biologics Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Pandemic Influenza Vaccine Distributors List
Table 165. Pandemic Influenza Vaccine Customers List
Table 166. Pandemic Influenza Vaccine Market Trends
Table 167. Pandemic Influenza Vaccine Market Drivers
Table 168. Pandemic Influenza Vaccine Market Challenges
Table 169. Pandemic Influenza Vaccine Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Pandemic Influenza Vaccine Product Picture
Figure 2. Global Pandemic Influenza Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Pandemic Influenza Vaccine Market Share by Type in 2022 & 2029
Figure 4. Trivalent Influenza Vaccine Product Picture
Figure 5. Quadrivalent Influenza Vaccine Product Picture
Figure 6. Global Pandemic Influenza Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Pandemic Influenza Vaccine Market Share by Application in 2022 & 2029
Figure 8. 6 Months to 3 Years
Figure 9. > 3 Years
Figure 10. Pandemic Influenza Vaccine Report Years Considered
Figure 11. Global Pandemic Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Pandemic Influenza Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Pandemic Influenza Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Pandemic Influenza Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Pandemic Influenza Vaccine Sales 2018-2029 ((M Units)
Figure 16. Global Pandemic Influenza Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Pandemic Influenza Vaccine Sales YoY (2018-2029) & (M Units)
Figure 18. US & Canada Pandemic Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Pandemic Influenza Vaccine Sales YoY (2018-2029) & (M Units)
Figure 20. Europe Pandemic Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Pandemic Influenza Vaccine Sales YoY (2018-2029) & (M Units)
Figure 22. China Pandemic Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Pandemic Influenza Vaccine Sales YoY (2018-2029) & (M Units)
Figure 24. Asia (excluding China) Pandemic Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales YoY (2018-2029) & (M Units)
Figure 26. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Pandemic Influenza Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Pandemic Influenza Vaccine in the World: Market Share by Pandemic Influenza Vaccine Revenue in 2022
Figure 29. Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Pandemic Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Pandemic Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Pandemic Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Pandemic Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Pandemic Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Pandemic Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Pandemic Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Pandemic Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Pandemic Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Pandemic Influenza Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Pandemic Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Pandemic Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Pandemic Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Pandemic Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Pandemic Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Pandemic Influenza Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Pandemic Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Pandemic Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Pandemic Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Pandemic Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Pandemic Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Pandemic Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Pandemic Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Pandemic Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Pandemic Influenza Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Pandemic Influenza Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Pandemic Influenza Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Pandemic Influenza Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Pandemic Influenza Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Pandemic Influenza Vaccine Value Chain
Figure 80. Pandemic Influenza Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed